Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize

Authors

  • Luís Castelo-Branco Serviço de Oncologia Médica. Centro Hospitalar e Universitário do Algarve. Faro. Portugal. Departamento de Epidemiologia. Escola Nacional de Saúde Pública. Universidade NOVA de Lisboa. Lisboa.
  • Inês Pires Silva Melanoma Institute Australia. Sydney.
  • Helena Canhão Departamento de Epidemiologia. Escola Nacional de Saúde Pública. Universidade NOVA de Lisboa. Lisboa. Centro de Estudos de Doenças Crónicas/ Chronic Diseases Research Center – CEDOC. Epidemiology of Chronic Diseases Unit – EpiDoC. NOVA Medical School. Universidade NOVA de Lisboa. Lisboa. Serviço de Reumatologia. Hospital Curry Cabral. Centro Hospitalar e Universitário de Lisboa Central. Lisboa.
  • Ahmad Awada Medical Oncology Institut Jules Bordet. Université Libre de Bruxelles. Brussels.

DOI:

https://doi.org/10.20344/amp.12040

Keywords:

Immunotherapy, Medical Oncology, Neoplasms/drug therapy, Neoplasms/immunology, Programmed Cell Death 1 Receptor

Abstract

N/a.

Downloads

Download data is not yet available.

Downloads

Published

2019-04-30

How to Cite

1.
Castelo-Branco L, Silva IP, Canhão H, Awada A. Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize. Acta Med Port [Internet]. 2019 Apr. 30 [cited 2024 Nov. 22];32(4):251-7. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/12040

Issue

Vol. 32 No. 4 (2019): April

Section

Perspective

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC